Our magazine is free!

for living with diabetes

Merck buying into ‘smart insulin’ market

Drugmaker Merck is buying privately held company SmartCells, which is developing an experimental form of “intelligent insulin,” according to a recent article from the Financial Times.  The deal is reportedly worth $500 million.

The smart insulin, which is currently being developed, is supposed to be self-regulating, meaning that it is released only when it is needed due to elevated blood sugar levels.

The acquisition marks Merck’s move into the insulin space at a time when other large drugmakers have tried to break into the market traditionally dominated by Novo Nordisk, Eli Lilly and Sanofi-Aventis.


Tags: ,
Sign up to our Magazine »

Leave a Comment

Submit Comment »

No Comments Yet!


nl-imageDirect to your inbox, our

free online magazine.

Sign up for the Desang Diabetes Magazine for new products, special offers and news.

*We will never email you more often than once a week (usually once a month). You can easily unsubscribe at any time. It’s finger-pricking good!

Close Don't show again